Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma.

Preclinical studies demonstrated that complement promotes tumor growth. Therefore, we sought to determine the best target for complement-based therapy amongst common human malignancies. High expression of eleven complement genes was linked to unfavorable prognosis in renal cell carcinoma. Complement...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Immunol
Autores principales: Reese, Britney, Silwal, Ashok, Daugherity, Elizabeth, Daugherity, Michael, Arabi, Mahshid, Daly, Pierce, Paterson, Yvonne, Woolford, Layton, Christie, Alana, Elias, Roy, Brugarolas, James, Wang, Tao, Karbowniczek, Magdalena, Markiewski, Maciej M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7703597/
https://ncbi.nlm.nih.gov/pubmed/33158953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.2000511
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares